Clinical trialNCT00377949CompletedObservational

Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients

SponsorGeorgetown UniversityEnrollment602Pulmonary Arterial HypertensionPulmonary HypertensionSclerodermaSystemic Sclerosis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the timeline of progression from pre-pulmonary hypertension to diagnosable pulmonary hypertension based on right heart catheterization. Moreover, to determine the timeline for progression from diagnosable pulmonary hypertension to clinical worsening of disease as defined as death, hospitalization, or worsening of PHT symptoms.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Virginia D. Steen, MD
Georgetown University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Ucla Medical Center
Los Angeles, California, United States
Stanford University
Stanford, California, United States
National Jewish Medical and Research Center
Denver, Colorado, United States
Georgetown University Medical Center
Washington D.C., District of Columbia, United States
Northwestern University
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
Louisiana State University Health Science Center
New Orleans, Louisiana, United States
John Hopkins University Medical Center
Baltimore, Maryland, United States
Boston University Medical School
Boston, Massachusetts, United States
Tufts Medical Center
Boston, Massachusetts, United States
University of Massachussetts Memorial Medical Center
Worcester, Massachusetts, United States
University of Michigan-Scleroderma Program
Ann Arbor, Michigan, United States
Hennepin County Medical Center
Minneapolis, Minnesota, United States
University of Minnesota
Minneapolis, Minnesota, United States
University of Medicine and Dentistry of New Jersey
New Brunswick, New Jersey, United States
Center for Rheumatology
Albany, New York, United States
North Shore Long Island Jewish Medical Center
New Hyde Park, New York, United States
Cornell University
New York, New York, United States
Hospital for Special Surgery
New York, New York, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
the University of Texas Health Science Center
Houston, Texas, United States
University of Utah
Salt Lake City, Utah, United States
the Medical College of Wisconsin
Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Feb 2005
Primary completion: 31 Jan 2016
Completion: —
Last update posted: 3 May 2016
Registered enrollment: 602
Registry id: NCT00377949

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.